Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male

Shinta Mizuno; Atsushi Nakazawa; Ayumi Ogawa; Tadakazu Hisamatsu; Shigemichi Hirose; Nobuhiro Tsukada

doi:10.1007/s12328-015-0575-x

Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male

Shinta Mizuno, Atsushi Nakazawa, Ayumi Ogawa, Tadakazu Hisamatsu, Shigemichi Hirose, Nobuhiro Tsukada

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

A 29-year-old male was diagnosed with ileocolic Crohn’s disease (CD) approximately 2 years ago. Adalimumab was prescribed as CD remission induction therapy. Three months after beginning adalimumab, watery diarrhea and lower abdominal pain developed. He was admitted under a diagnosis of CD exacerbation. Despite fasting and antibiotic treatment, symptoms of acute panperitonitis appeared. He was diagnosed as acute appendicitis and we performed emergency surgery for peritoneal drainage and ileocecal resection on the fifth hospital day. We diagnosed periappendicitis based on the operative findings. This is the first report of periappendicitis with CD during adalimumab treatment.

Original language	English
Pages (from-to)	134-137
Number of pages	4
Journal	Clinical journal of gastroenterology
Volume	8
Issue number	3
DOIs	https://doi.org/10.1007/s12328-015-0575-x
Publication status	Published - 2015 Jun 30

Keywords

Adalimumab
Crohn’s disease
Periappendicitis

ASJC Scopus subject areas

Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12328-015-0575-x

Cite this

@article{37fe6db6b18f49229079f74198786afe,

title = "Periappendicitis during adalimumab treatment for ileocecal Crohn{\textquoteright}s disease in a 29-year-old male",

abstract = "A 29-year-old male was diagnosed with ileocolic Crohn{\textquoteright}s disease (CD) approximately 2 years ago. Adalimumab was prescribed as CD remission induction therapy. Three months after beginning adalimumab, watery diarrhea and lower abdominal pain developed. He was admitted under a diagnosis of CD exacerbation. Despite fasting and antibiotic treatment, symptoms of acute panperitonitis appeared. He was diagnosed as acute appendicitis and we performed emergency surgery for peritoneal drainage and ileocecal resection on the fifth hospital day. We diagnosed periappendicitis based on the operative findings. This is the first report of periappendicitis with CD during adalimumab treatment.",

keywords = "Adalimumab, Crohn{\textquoteright}s disease, Periappendicitis",

author = "Shinta Mizuno and Atsushi Nakazawa and Ayumi Ogawa and Tadakazu Hisamatsu and Shigemichi Hirose and Nobuhiro Tsukada",

note = "Publisher Copyright: {\textcopyright} 2015, Springer Japan.",

year = "2015",

month = jun,

day = "30",

doi = "10.1007/s12328-015-0575-x",

language = "English",

volume = "8",

pages = "134--137",

journal = "Clinical Journal of Gastroenterology",

issn = "1865-7257",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male

AU - Mizuno, Shinta

AU - Nakazawa, Atsushi

AU - Ogawa, Ayumi

AU - Hisamatsu, Tadakazu

AU - Hirose, Shigemichi

AU - Tsukada, Nobuhiro

PY - 2015/6/30

Y1 - 2015/6/30

N2 - A 29-year-old male was diagnosed with ileocolic Crohn’s disease (CD) approximately 2 years ago. Adalimumab was prescribed as CD remission induction therapy. Three months after beginning adalimumab, watery diarrhea and lower abdominal pain developed. He was admitted under a diagnosis of CD exacerbation. Despite fasting and antibiotic treatment, symptoms of acute panperitonitis appeared. He was diagnosed as acute appendicitis and we performed emergency surgery for peritoneal drainage and ileocecal resection on the fifth hospital day. We diagnosed periappendicitis based on the operative findings. This is the first report of periappendicitis with CD during adalimumab treatment.

AB - A 29-year-old male was diagnosed with ileocolic Crohn’s disease (CD) approximately 2 years ago. Adalimumab was prescribed as CD remission induction therapy. Three months after beginning adalimumab, watery diarrhea and lower abdominal pain developed. He was admitted under a diagnosis of CD exacerbation. Despite fasting and antibiotic treatment, symptoms of acute panperitonitis appeared. He was diagnosed as acute appendicitis and we performed emergency surgery for peritoneal drainage and ileocecal resection on the fifth hospital day. We diagnosed periappendicitis based on the operative findings. This is the first report of periappendicitis with CD during adalimumab treatment.

KW - Adalimumab

KW - Crohn’s disease

KW - Periappendicitis

UR - http://www.scopus.com/inward/record.url?scp=84933278294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933278294&partnerID=8YFLogxK

U2 - 10.1007/s12328-015-0575-x

DO - 10.1007/s12328-015-0575-x

M3 - Article

C2 - 26023062

AN - SCOPUS:84933278294

SN - 1865-7257

VL - 8

SP - 134

EP - 137

JO - Clinical Journal of Gastroenterology

JF - Clinical Journal of Gastroenterology

IS - 3

ER -

Periappendicitis during adalimumab treatment for ileocecal Crohn’s disease in a 29-year-old male

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this